Medorb Pharmaceutical Private Limited
About Medorb Pharmaceutical Private Limited
Data last updated:
Medorb Pharmaceutical Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 September 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24290RJ2016PTC055894. Its GSTIN is 08AAKCM5711F1ZI (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sharda Devi Meena and Sunil Kumar Kothiwala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Jaipur, Rajasthan.
As per the financials filed for FY 2025, the company reported a revenue of ₹55,174, a decline of 96% compared to the previous year. For the same year it recorded a net loss of ₹17.64 Lakh and EBITDA of -₹17.36 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 76% over three years and 63% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Medorb Pharmaceutical Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot Num 08 First Floor, New Colony Near Railway Line, Jaipur, Rajasthan, India – 302017
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medorb Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medorb Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medorb Pharmaceutical Private Limited, buy the company report.
Financials of Medorb Pharmaceutical Private Limited
FY 2025 filings availableMedorb Pharmaceutical Private Limited reported revenue of ₹55,174 (down 96% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 63% over five years, including a 96% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹17.36 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹17.64 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medorb Pharmaceutical Private Limited, buy the company report.
Board of directors of Medorb Pharmaceutical Private Limited
Medorb Pharmaceutical has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sharda Devi Meena | Director | 19 Jun 2017 | 9 Years 4 Months | Current |
| Sunil Kumar Kothiwala | Director | 01 May 2021 | 5 Years 5 Months | Current |
Auditor
Medorb Pharmaceutical Private Limited is audited by CHOUDHARY GUPTA & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CHOUDHARY GUPTA & CO | FY 2018 | 003165C |
Shareholding
The shareholding of Medorb Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Medorb Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medorb Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medorb Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medorb Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAKCM5711F1ZI | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medorb Pharmaceutical Private Limited, buy the company report.
Recent activity
Medorb Pharmaceutical Private Limited has 7 board changes on record since 2017: 2 appointments and 5 cessations. The latest: Sunil Kumar Kothiwala was appointed as Director on 01 May 2021.
Frequently asked questions
Medorb Pharmaceutical is an active private limited company based in Jaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 September 2016 (10+ years old) and is registered under CIN U24290RJ2016PTC055894.
Medorb Pharmaceutical has 2 current directors:
- Sharda Devi Meena - Director
- Sunil Kumar Kothiwala - Director
The latest financial statements of Medorb Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Medorb Pharmaceutical is 08AAKCM5711F1ZI, registered in Rajasthan.
The CIN (Corporate Identification Number) of Medorb Pharmaceutical is U24290RJ2016PTC055894. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medorb Pharmaceutical was incorporated on 05 September 2016, making it 10+ years old. It is registered with the Registrar of Companies, Jaipur.
Sunil Kumar Kothiwala was appointed as Director on 01 May 2021. Yogendra Sharma ceased to be Director on 01 May 2021. Amit Kumar ceased to be Director on 19 Sep 2019. Medorb Pharmaceutical has 7 board changes on record in total.
The registered office of Medorb Pharmaceutical is at Plot Num 08 First Floor, New Colony Near Railway Line, Jaipur, Rajasthan, India – 302017.
Medorb Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Medorb Pharmaceutical is compliant as of 28 August 2026. The company is actively filing with the Registrar of Companies.